GoAI
Get started
OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

NASDAQHealthcareMedical - Instruments & Supplies

Open in GoAI

Regular session

$3.775

−$0.105 · -2.71%

Aug 24, 1:41 PM ET

OSUR company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

47

Fair Value

Momentum

61

Gaining

Sentiment

57

Mixed

Risk resilience

59

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $3.775

52-week range

Current $3.775

Open
$3.835
Previous close
$3.88
Volume
179.79K
Market cap
259.9M USD
50-day average
$4.106
-8.06% below average
200-day average
$3.1936
+18.21% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
-8.25M USD
P/E (TTM)
-5.47×
P/B (TTM)
0.82×
P/S (TTM)
2.31×
EV / EBITDA
0.14×
Earnings yield
-38.65%
Free cash flow yield
-0.03%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
41.38%
Operating margin
-44.75%
Net margin
-43.70%
Return on equity
-20.17%
Return on assets
-17.05%
Return on invested capital
-18.63%

Financial health

Debt / equity
0.04×
Current ratio
6.58×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends61%17%-27%-71%Gross margin, FY2021: 50.33%Gross margin, FY2022: 38.31%Gross margin, FY2023: 44.25%Gross margin, FY2024: 41.02%Gross margin, FY2025: 41.90%Operating margin, FY2021: -4.99%Operating margin, FY2022: -1.35%Operating margin, FY2023: 13.34%Operating margin, FY2024: -11.09%Operating margin, FY2025: -59.23%Net margin, FY2021: -9.84%Net margin, FY2022: -4.42%Net margin, FY2023: 13.23%Net margin, FY2024: -10.49%Net margin, FY2025: -59.76%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 50.33%. Gross margin FY2022 38.31%. Gross margin FY2023 44.25%. Gross margin FY2024 41.02%. Gross margin FY2025 41.90%. Operating margin FY2021 -4.99%. Operating margin FY2022 -1.35%. Operating margin FY2023 13.34%. Operating margin FY2024 -11.09%. Operating margin FY2025 -59.23%. Net margin FY2021 -9.84%. Net margin FY2022 -4.42%. Net margin FY2023 13.23%. Net margin FY2024 -10.49%. Net margin FY2025 -59.76%.

Income trends

Revenue

115.02M USD-38.10%

Operating income

−68.12M USD-230.70%

Net income

−68.73M USD-252.47%
Income trends across reported periods452.89M USD263.21M USD73.53M USD−116.15M USDRevenue, FY2021: 233.67M USDRevenue, FY2022: 387.48M USDRevenue, FY2023: 405.47M USDRevenue, FY2024: 185.83M USDRevenue, FY2025: 115.02M USDOperating income, FY2021: −11.65M USDOperating income, FY2022: −5.24M USDOperating income, FY2023: 54.08M USDOperating income, FY2024: −20.6M USDOperating income, FY2025: −68.12M USDNet income, FY2021: −23M USDNet income, FY2022: −17.13M USDNet income, FY2023: 53.66M USDNet income, FY2024: −19.5M USDNet income, FY2025: −68.73M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 233.67M USD. Revenue FY2022 387.48M USD. Revenue FY2023 405.47M USD. Revenue FY2024 185.83M USD. Revenue FY2025 115.02M USD. Operating income FY2021 −11.65M USD. Operating income FY2022 −5.24M USD. Operating income FY2023 54.08M USD. Operating income FY2024 −20.6M USD. Operating income FY2025 −68.12M USD. Net income FY2021 −23M USD. Net income FY2022 −17.13M USD. Net income FY2023 53.66M USD. Net income FY2024 −19.5M USD. Net income FY2025 −68.73M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue115.02M USD185.83M USD405.47M USD387.48M USD233.67M USD
Cost of goods sold66.82M USD109.6M USD226.05M USD239.04M USD116.07M USD
Gross profit48.2M USD76.23M USD179.42M USD148.44M USD117.6M USD
Research and development42.53M USD24.42M USD33.16M USD36.24M USD34.17M USD
Selling, general, and administrative73.79M USD72.41M USD92.18M USD117.44M USD95.08M USD
Operating expenses116.32M USD96.83M USD125.34M USD153.68M USD129.25M USD
Depreciation and amortization9.97M USD10.87M USD19.9M USD14M USD11.66M USD
Operating income−68.12M USD−20.6M USD54.08M USD−5.24M USD−11.65M USD
Net income−68.73M USD−19.5M USD53.66M USD−17.13M USD−23M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

13 ratings
Strong buy00%
Buy431%
Hold969%
Sell00%
Strong sell00%

OSUR news

seekingalpha.com

OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript

Read source
marketbeat.com

OraSure Technologies Q2 Earnings Call Highlights

OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth in sample-management…

Read source
globenewswire.com

OraSure Announces Second Quarter 2026 Financial Results

BETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for…

Read source
globenewswire.com

OraSure Announces Second Quarter 2026 Financial Results

BETHLEHEM, Pa. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for…

Read source
globenewswire.com

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market…

Read source
globenewswire.com

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic individuals and deceased patients. The rapid test detects the Bundibugyo virus associated…

Read source

OSUR peers

Amgen Inc. logo

AMGN

Amgen Inc.

$440.91

+0.36%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.41

+0.20%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$549.02

+0.18%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$376.28

-0.67%

Sanofi logo

SNY

Sanofi

$45.63

-0.48%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$826.32

-0.93%

ETFs holding OSUR

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
8.7M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$377.39-0.22%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
6.65M
Weight
0.01%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$298.07-0.63%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
3.26M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$243.46-0.85%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
2.32M
Weight
0.02%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.06-0.33%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
1.49M
Weight
0.01%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$120.51-0.61%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
1.3M
Weight
0.01%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.465-1.06%
U.S. Micro Cap Portfolio ETF logoU.S. Micro Cap Portfolio ETFDFMC
Market value
911.33K
Weight
0.01%
AUM
8.06B USD
Expense ratio
0.43%
Price / 1D
$60.63-0.57%
Dimensional - US Small Cap ETF logoDimensional - US Small Cap ETFDFAS
Market value
886.64K
Weight
0.01%
AUM
15.92B USD
Expense ratio
0.26%
Price / 1D
$82.54-0.58%

Continue in GoAI

Research OSUR

research.disclaimer